RO5212054 (PLX3603)

RO5212054 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5212054 (PLX3603), covering 2017-07-28 to 2017-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors [Phase 1]